Salisig, Baby Girl .
HRN: 26-94-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
04/07/2025
04/13/2025
IV
17.5mg
Q24
Acute Bacterial Infection(thickly Msaf)
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes